DexCom Operating Expenses 2010-2025 | DXCM
DexCom annual/quarterly operating expenses history and growth rate from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
- DexCom operating expenses for the quarter ending June 30, 2025 were $0.945B, a 11.6% increase year-over-year.
- DexCom operating expenses for the twelve months ending June 30, 2025 were $3.614B, a 11.07% increase year-over-year.
- DexCom annual operating expenses for 2024 were $3.433B, a 13.5% increase from 2023.
- DexCom annual operating expenses for 2023 were $3.025B, a 20.09% increase from 2022.
- DexCom annual operating expenses for 2022 were $2.519B, a 15.39% increase from 2021.
| DexCom Annual Operating Expenses (Millions of US $) |
|
|---|---|
| 2024 | $3,433 |
| 2023 | $3,025 |
| 2022 | $2,519 |
| 2021 | $2,183 |
| 2020 | $1,627 |
| 2019 | $1,334 |
| 2018 | $1,218 |
| 2017 | $761 |
| 2016 | $637 |
| 2015 | $459 |
| 2014 | $281 |
| 2013 | $189 |
| 2012 | $156 |
| 2011 | $121 |
| 2010 | $94 |
| 2009 | $76 |
| DexCom Quarterly Operating Expenses (Millions of US $) |
|
|---|---|
| 2025-06-30 | $945 |
| 2025-03-31 | $902 |
| 2024-12-31 | $925 |
| 2024-09-30 | $842 |
| 2024-06-30 | $846 |
| 2024-03-31 | $820 |
| 2023-12-31 | $818 |
| 2023-09-30 | $770 |
| 2023-06-30 | $743 |
| 2023-03-31 | $694 |
| 2022-12-31 | $690 |
| 2022-09-30 | $622 |
| 2022-06-30 | $619 |
| 2022-03-31 | $588 |
| 2021-12-31 | $698 |
| 2021-09-30 | $532 |
| 2021-06-30 | $494 |
| 2021-03-31 | $459 |
| 2020-12-31 | $465 |
| 2020-09-30 | $407 |
| 2020-06-30 | $384 |
| 2020-03-31 | $372 |
| 2019-12-31 | $361 |
| 2019-09-30 | $340 |
| 2019-06-30 | $337 |
| 2019-03-31 | $295 |
| 2018-12-31 | $503 |
| 2018-09-30 | $253 |
| 2018-06-30 | $247 |
| 2018-03-31 | $215 |
| 2017-12-31 | $209 |
| 2017-09-30 | $185 |
| 2017-06-30 | $184 |
| 2017-03-31 | $183 |
| 2016-12-31 | $177 |
| 2016-09-30 | $167 |
| 2016-06-30 | $157 |
| 2016-03-31 | $135 |
| 2015-12-31 | $129 |
| 2015-09-30 | $148 |
| 2015-06-30 | $97 |
| 2015-03-31 | $86 |
| 2014-12-31 | $83 |
| 2014-09-30 | $74 |
| 2014-06-30 | $65 |
| 2014-03-31 | $59 |
| 2013-12-31 | $54 |
| 2013-09-30 | $49 |
| 2013-06-30 | $46 |
| 2013-03-31 | $41 |
| 2012-12-31 | $42 |
| 2012-09-30 | $40 |
| 2012-06-30 | $38 |
| 2012-03-31 | $36 |
| 2011-12-31 | $35 |
| 2011-09-30 | $32 |
| 2011-06-30 | $29 |
| 2011-03-31 | $26 |
| 2010-12-31 | $26 |
| 2010-09-30 | $25 |
| 2010-06-30 | $23 |
| 2010-03-31 | $21 |
| 2009-12-31 | $20 |
| 2009-09-30 | $19 |
| 2009-06-30 | $20 |
| 2009-03-31 | $17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $31.357B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $183.063B | 22.15 |
| Intuitive Surgical (ISRG) | United States | $172.911B | 71.67 |
| IDEXX Laboratories (IDXX) | United States | $53.117B | 55.28 |
| Edwards Lifesciences (EW) | United States | $45.606B | 30.23 |
| Alcon (ALC) | Switzerland | $42.656B | 28.83 |
| IQVIA Holdings (IQV) | United States | $32.339B | 18.27 |
| Mettler-Toledo (MTD) | United States | $27.274B | 32.37 |
| STERIS (STE) | Ireland | $24.334B | 25.90 |
| Waters (WAT) | United States | $17.669B | 24.27 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.740B | 0.00 |
| Hologic (HOLX) | United States | $15.342B | 16.62 |
| Penumbra (PEN) | United States | $10.038B | 73.33 |
| Sysmex ADR (SSMXY) | Japan | $8.699B | 27.64 |
| Globus Medical (GMED) | United States | $8.500B | 19.56 |
| Masimo (MASI) | United States | $8.473B | 28.51 |
| Teleflex (TFX) | United States | $5.432B | 8.77 |
| Glaukos (GKOS) | United States | $5.264B | 0.00 |
| TransMedics (TMDX) | United States | $4.501B | 68.42 |
| Integer Holdings (ITGR) | United States | $3.839B | 19.16 |
| LivaNova (LIVN) | United Kingdom | $2.897B | 16.58 |
| Veracyte (VCYT) | United States | $2.414B | 33.35 |
| Alphatec Holdings (ATEC) | United States | $2.338B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.247B | 0.00 |
| Artivion (AORT) | United States | $2.063B | 104.12 |
| Nihon Kohden (NHNKY) | Japan | $2.052B | 24.49 |
| Elekta AB (EKTAY) | Sweden | $1.874B | 16.84 |
| Pulse Biosciences (PLSE) | United States | $1.130B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.100B | 6.30 |
| OPKO Health (OPK) | United States | $1.072B | 0.00 |
| IRadimed (IRMD) | United States | $0.903B | 43.83 |
| Tandem Diabetes Care (TNDM) | United States | $0.752B | 0.00 |
| AxoGen (AXGN) | United States | $0.679B | 0.00 |
| SiBone (SIBN) | United States | $0.677B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.656B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.552B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.527B | 4.23 |
| OrthoPediatrics (KIDS) | United States | $0.504B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.499B | 8.81 |
| Treace Medical Concepts (TMCI) | United States | $0.436B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.389B | 92.58 |
| Pacific Biosciences Of California (PACB) | United States | $0.384B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.381B | 9.69 |
| AngioDynamics (ANGO) | United States | $0.368B | 0.00 |
| RxSight (RXST) | United States | $0.340B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.339B | 0.00 |
| NeuroPace (NPCE) | United States | $0.308B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.290B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.289B | 19.92 |
| Neuronetics (STIM) | United States | $0.256B | 0.00 |
| 908 Devices (MASS) | United States | $0.253B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.226B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.223B | 0.00 |
| Inogen (INGN) | United States | $0.208B | 0.00 |
| CVRx (CVRX) | United States | $0.202B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.168B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.144B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.128B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.106B | 0.00 |
| InspireMD (NSPR) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
| Hyperfine (HYPR) | United States | $0.099B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.088B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.057B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 0.00 |
| Positron (POSC) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.018B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.14 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |